DLX5 and lymphoma: Lymphoma cells from Lck-Dlx5;Lck-MyrAkt2 mice were treated with PFK118-310 at 1 μM for 20 h and then subjected to whole transcriptome analysis, which revealed altered expression of genes encoding Srebf2-cholesterol synthesis pathway members and cell cycle regulators (Fig. 4A).